BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30185549)

  • 21. MicroRNA-192 suppresses liver metastasis of colon cancer.
    Geng L; Chaudhuri A; Talmon G; Wisecarver JL; Are C; Brattain M; Wang J
    Oncogene; 2014 Nov; 33(46):5332-40. PubMed ID: 24213572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinoma.
    Li M; Zhao X; Liu Y; An J; Xiao H; Wang C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2205-2213. PubMed ID: 28220308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and Prognostic Significance of CDK8 and β-Catenin in Hepatocellular Carcinoma.
    Han SI; Lim SC
    In Vivo; 2020; 34(3):1387-1394. PubMed ID: 32354935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis.
    McCleland ML; Soukup TM; Liu SD; Esensten JH; de Sousa e Melo F; Yaylaoglu M; Warming S; Roose-Girma M; Firestein R
    J Pathol; 2015 Dec; 237(4):508-19. PubMed ID: 26235356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.
    Firestein R; Bass AJ; Kim SY; Dunn IF; Silver SJ; Guney I; Freed E; Ligon AH; Vena N; Ogino S; Chheda MG; Tamayo P; Finn S; Shrestha Y; Boehm JS; Jain S; Bojarski E; Mermel C; Barretina J; Chan JA; Baselga J; Tabernero J; Root DE; Fuchs CS; Loda M; Shivdasani RA; Meyerson M; Hahn WC
    Nature; 2008 Sep; 455(7212):547-51. PubMed ID: 18794900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/β-Catenin Signaling.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.
    Chen M; Liu Y; Varley P; Chang Y; He XX; Huang H; Tang D; Lotze MT; Lin J; Tsung A
    Cancer Res; 2015 Apr; 75(8):1645-56. PubMed ID: 25720799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.
    Lu MH; Huang CC; Pan MR; Chen HH; Hung WC
    Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
    Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
    Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
    [No Abstract]   [Full Text] [Related]  

  • 30. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
    Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
    Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells.
    Lin H; Zhang Y; Wang H; Xu D; Meng X; Shao Y; Lin C; Ye Y; Qian H; Wang S
    Cancer Gene Ther; 2012 Dec; 19(12):845-51. PubMed ID: 23037807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
    Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer.
    Serrao A; Jenkins LM; Chumanevich AA; Horst B; Liang J; Gatza ML; Lee NY; Roninson IB; Broude EV; Mythreye K
    Oncogene; 2018 Aug; 37(35):4792-4808. PubMed ID: 29780169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
    Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
    Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase.
    Sooraj D; Sun C; Doan A; Garama DJ; Dannappel MV; Zhu D; Chua HK; Mahara S; Wan Hassan WA; Tay YK; Guanizo A; Croagh D; Prodanovic Z; Gough DJ; Wan C; Firestein R
    Mol Cell; 2022 Jan; 82(1):123-139.e7. PubMed ID: 34910943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.
    Xi M; Chen T; Wu C; Gao X; Wu Y; Luo X; Du K; Yu L; Cai T; Shen R; Sun H
    Eur J Med Chem; 2019 Feb; 164():77-91. PubMed ID: 30594029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3.
    Zhang J; Lang Y; Guo L; Pei Y; Hao S; Liang Z; Su G; Shu L; Liu H; Huang C; Xu J
    Cell Physiol Biochem; 2018; 50(6):2176-2187. PubMed ID: 30415251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
    Jia P; Wei G; Zhou C; Gao Q; Wu Y; Sun X; Li X
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618765221. PubMed ID: 29618288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.